Sonnet BioTherapeutics

$2.09
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.01 (-0.47%) Today
-$0.03 (-1.42%) As of 11:10 PM UTC after-hours

Why Robinhood?

You can buy or sell SONN and other stocks, options, and ETFs commission-free!

About SONN

Sonnet BioTherapeutics Holdings, Inc. engages in the development of biologic drugs with enhanced single or bispecific mechanisms. Its technology utilizes a fully human single chain antibody fragment that binds to and hitch-hikes on human serum albumin for transport to target tissues.

CEO
Pankaj Mohan
Employees
9
Headquarters
Princeton, New Jersey
Founded
2011
Market Cap
38.70M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
626.30K
High Today
$2.14
Low Today
$2.02
Open Price
$2.12
Volume
412.70K
52 Week High
$16.20
52 Week Low
$1.81

SONN Earnings

-$4.73
-$3.15
-$1.58
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected May 12, Pre-Market

You May Also Like

KZIA
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure